Search Results - "Dahlof, Carl G.H."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    Randomized, controlled trial of telcagepant over four migraine attacks by Ho, Andrew P, Dahlöf, Carl Gh, Silberstein, Stephen D, Saper, Joel R, Ashina, Messoud, Kost, James T, Froman, Samar, Leibensperger, Heather, Lines, Christopher R, Ho, Tony W

    Published in Cephalalgia (01-12-2010)
    “…This study evaluated the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack and…”
    Get more information
    Journal Article
  3. 3

    Prevalence and Diagnosis of Migraine in Patients Consulting Their Physician With a Complaint of Headache: Data From the Landmark Study by Tepper, Stewart J., Dahlöf, Carl G.H., Dowson, Andrew, Newman, Lawrence, Mansbach, Hank, Jones, Martin, Pham, Ba, Webster, Chris, Salonen, Reijo

    Published in Headache (01-10-2004)
    “…Context.—Headache experts have suggested that to improve the recognition of migraine, patients with a stable pattern of episodic, disabling headache and a…”
    Get full text
    Journal Article
  4. 4

    Applications of Computerized Adaptive Testing (CAT) to the Assessment of Headache Impact by Ware, John E., Kosinski, Mark, Bjorner, Jakob B., Bayliss, Martha S., Alice Batenhorst, Carl G. H. Dahlöf, Stewart Tepper, Andrew Dowson

    Published in Quality of life research (01-12-2003)
    “…Objective: To evaluate the feasibility of computerized adaptive testing (CAT) and the reliability and validity of CAT-based estimates of headache impact scores…”
    Get full text
    Journal Article
  5. 5

    Rizatriptan in the treatment of migraine by Dahlof, Carl G.H., Rapoport, Alan M., Sheftell, Fred D., Lines, Christopher R.

    Published in Clinical therapeutics (01-11-1999)
    “…Rizatriptan is a selective 5-hydroxytriptamine 1B/1D receptor agonist that was launched in 1998 for the acute treatment of migraine in adults. Based on data…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The burden of migraine to the individual sufferer: a review by Dahlof, CG, Solomon, GD

    Published in European journal of neurology (01-11-1998)
    “…This review of the literature reveals that migraine is a common, chronic condition featuring episodic attacks which vary in severity and symptomatology…”
    Get full text
    Journal Article
  8. 8

    How Does Almotriptan Compare With Other Triptans? A Review of Data From Placebo-Controlled Clinical Trials by Dahlöf, Carl G.H., Dodick, David, Dowson, Andrew J., Pascual, Julio

    Published in Headache (01-02-2002)
    “…Almotriptan, the new selective 5‐HT1B/1D agonist, has a higher oral bioavailability than any other triptan, with more than two thirds of the administered dose…”
    Get full text
    Journal Article
  9. 9

    Non-oral formulations of triptans and their use in acute migraine by Dahlöf, Carl G H

    Published in Current pain and headache reports (01-06-2005)
    “…The introduction of triptans (5-HT (1B/1D) agonists) into clinical practice has expanded the therapeutic options for doctors treating migraine sufferers. The…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    The burden of migraine to the individual suffer: a review by Dahlöf, Carl G.H., Solomon, Glen D.

    Published in European journal of neurology (01-11-1998)
    “…This review of the literature reveals that migraine is a common, chronic condition featuring episodic attacks which vary in severity and sympatomatology…”
    Get full text
    Journal Article
  13. 13

    Sumatriptan Injection and Tablets in Clinical Practice: Results of a Survey of 707 Migraineurs by Dahlöf, Carl G.H., Saiers, Jane

    Published in Headache (01-11-1998)
    “…This report from the Gothenburg Migraine Clinic in Sweden describes the results of a telephone survey of over 700 patients using open‐label sumatriptan tablets…”
    Get full text
    Journal Article
  14. 14

    Measuring disability and quality of life in migraine by Dahlöf, Carl G H

    Published in Drugs of today (Barcelona, Spain : 1998) (01-01-2003)
    “…Although eight out of ten people suffer from different types of headaches, the severity of their pain is often not communicated properly to their doctors…”
    Get full text
    Journal Article